Table 4 Five-year relative survival rates.
From: Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology
Age≤14 | Age>14 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HW | NHW | BL | API | P-value | HW | NHW | BL | API | P-value | ||
ALL | |||||||||||
Total | 0.81(0.8,0.83) | 0.83(0.82,0.84) | 0.75(0.72,0.78) | 0.83(0.81,0.86) | <0.01 | Total | 0.32(0.3,0.34) | 0.3(0.29,0.31) | 0.24(0.2,0.31) | 0.35(0.31,0.39) | <0.01 |
Male | 0.81(0.79,0.83) | 0.82(0.8,0.83) | 0.74(0.7,0.78) | 0.81(0.77,0.84) | <0.01 | Male | 0.34(0.31,0.37) | 0.3(0.29,0.32) | 0.24(0.19,0.32) | 0.35(0.3,0.4) | <0.01 |
Female | 0.82(0.8,0.84) | 0.85(0.84,0.87) | 0.76(0.71,0.8) | 0.87(0.83,0.9) | 0.012 | Female | 0.29(0.25,0.32) | 0.29(0.27,0.31) | 0.24(0.19,0.31) | 0.34(0.28,0.4) | <0.01 |
≤4 | 0.84(0.82,0.86) | 0.86(0.84,0.87) | 0.75(0.7,0.8) | 0.88(0.85,0.91) | <0.01 | 15-34 | 0.43(0.39,0.46) | 0.5(0.48,0.53) | 0.36(0.3,0.53) | 0.47(0.4,0.53) | <0.01 |
5–9 | 0.83(0.8,0.86) | 0.85(0.83,0.87) | 0.81(0.75,0.86) | 0.78(0.72,0.83) | <0.01 | 35-54 | 0.23(0.19,0.27) | 0.28(0.25,0.31) | 0.19(0.13,0.31) | 0.36(0.29,0.43) | 0.047 |
10–14 | 0.7(0.66,0.74) | 0.73(0.7,0.76) | 0.67(0.59,0.73) | 0.73(0.64,0.8) | 0.005 | 55+ | 0.11(0.07,0.15) | 0.12(0.1,0.14) | 0.09(0.04,0.14) | 0.15(0.1,0.22) | 0.726 |
CLL | |||||||||||
Total | Total | 0.74(0.7,0.76) | 0.76(0.75,0.76) | 0.62(0.6,0.76) | 0.71(0.66,0.75) | <0.01 | |||||
Male | Male | 0.69(0.65,0.73) | 0.75(0.74,0.75) | 0.59(0.56,0.75) | 0.7(0.64,0.75) | <0.01 | |||||
Female | Female | 0.79(0.74,0.83) | 0.77(0.76,0.78) | 0.66(0.62,0.78) | 0.71(0.64,0.77) | <0.01 | |||||
≤4 | 15–34 | 0.79(0.47,0.93) | 0.76(0.66,0.84) | 0.63(0.37,0.84) | 0.5(0.01,0.91) | 0.359 | |||||
5–9 | 35–54 | 0.87(0.81,0.91) | 0.88(0.87,0.89) | 0.72(0.67,0.89) | 0.89(0.8,0.94) | <0.01 | |||||
10–14 | 55+ | 0.71(0.67,0.74) | 0.74(0.73,0.75) | 0.6(0.57,0.75) | 0.68(0.63,0.72) | <0.01 | |||||
AML | |||||||||||
Total | 0.52(0.47,0.57) | 0.51(0.48,0.55) | 0.46(0.4,0.52) | 0.48(0.41,0.55) | <0.01 | Total | 0.27(0.25,0.29) | 0.14(0.14,0.14) | 0.16(0.15,0.18) | 0.21(0.19,0.23) | <0.01 |
Male | 0.52(0.45,0.59) | 0.5(0.45,0.54) | 0.48(0.39,0.57) | 0.46(0.36,0.56) | 0.051 | Male | 0.26(0.24,0.28) | 0.13(0.12,0.13) | 0.16(0.14,0.13) | 0.18(0.16,0.2) | <0.01 |
Female | 0.52(0.44,0.59) | 0.54(0.49,0.58) | 0.44(0.35,0.52) | 0.51(0.4,0.61) | 0.011 | Female | 0.28(0.25,0.3) | 0.16(0.15,0.16) | 0.17(0.14,0.16) | 0.24(0.21,0.27) | <0.01 |
≤4 | 0.55(0.48,0.62) | 0.52(0.47,0.56) | 0.46(0.36,0.55) | 0.48(0.38,0.58) | 0.098 | 15–34 | 0.48(0.44,0.51) | 0.41(0.39,0.44) | 0.32(0.28,0.44) | 0.41(0.36,0.46) | 0.084 |
5–9 | 0.49(0.38,0.6) | 0.55(0.48,0.61) | 0.54(0.41,0.66) | 0.53(0.37,0.67) | 0.434 | 35–54 | 0.36(0.33,0.4) | 0.31(0.3,0.33) | 0.28(0.24,0.33) | 0.35(0.31,0.38) | 0.037 |
10–14 | 0.5(0.4,0.58) | 0.49(0.44,0.54) | 0.41(0.31,0.51) | 0.45(0.31,0.58) | 0.049 | 55+ | 0.09(0.07,0.11) | 0.07(0.06,0.07) | 0.07(0.05,0.07) | 0.1(0.08,0.11) | <0.01 |
CML | |||||||||||
Total | 0.54(0.39,0.67) | 0.56(0.48,0.64) | 0.47(0.31,0.62) | 0.6(0.41,0.75) | Total | 0.54(0.51,0.57) | 0.39(0.38,0.4) | 0.43(0.4,0.46) | 0.48(0.45,0.51) | <0.01 | |
Male | 0.43(0.26,0.59) | 0.54(0.43,0.64) | 0.53(0.29,0.71) | 0.58(0.35,0.76) | Male | 0.54(0.5,0.57) | 0.39(0.38,0.4) | 0.41(0.37,0.44) | 0.48(0.44,0.53) | 0.216 | |
Female | 0.72(0.43,0.88) | 0.6(0.46,0.71) | 0.41(0.19,0.62) | 0.66(0.26,0.88) | Female | 0.55(0.51,0.59) | 0.4(0.39,0.42) | 0.46(0.42,0.5) | 0.47(0.42,0.52) | <0.01 | |
≤4 | 0.46(0.29,0.62) | 0.57(0.44,0.68) | 0.32(0.09,0.58) | 0.62(0.33,0.81) | 15–34 | 0.66(0.6,0.71) | 0.59(0.56,0.63) | 0.56(0.5,0.62) | 0.66(0.58,0.73) | 0.134 | |
5–9 | 0.5(0.06,0.85) | 0.56(0.36,0.72) | 0.48(0.18,0.72) | 0.5(0.06,0.85) | 35–54 | 0.64(0.59,0.68) | 0.61(0.59,0.63) | 0.55(0.5,0.59) | 0.63(0.57,0.68) | <0.01 | |
10–14 | 0.66(0.34,0.85) | 0.56(0.42,0.68) | 0.57(0.3,0.77) | 0.62(0.27,0.84) | 55+ | 0.39(0.34,0.43) | 0.3(0.29,0.31) | 0.31(0.27,0.34) | 0.32(0.28,0.37) | 0.035 | |
